Early Signs of Lung Disease: A Regenerative Medicine Perspective

Every breath tells a story about your lung health, but recognising the early signs of respiratory damage isn’t easy. 

The lungs work continuously to maintain the body’s oxygen supply, yet the gradual changes that affect their function often go unnoticed. A persistent cough, breathlessness during routine activities or a decline in physical stamina may seem like minor inconveniences, but they can sometimes signal underlying respiratory changes. Many chronic lung conditions develop progressively, with inflammation, oxidative stress and cellular damage gradually affecting the delicate structures responsible for breathing and gas exchange.

Understanding the Early Signs of Lung Disease is crucial for timely diagnosis and understanding how respiratory damage develops. Conditions including chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis involve distinct patterns of tissue injury, each presenting different challenges for long-term lung health. Beyond conventional respiratory care, regenerative medicine is opening new avenues of research into cellular communication, inflammation and tissue repair. Emerging investigations into stem cells and their biological signalling properties are offering fresh perspectives on how damaged lung environments might be supported. While these approaches remain under investigation, they are reshaping scientific interest in the future of pulmonary care.

Ask The Expert

Early Signs of Lung Disease: Subtle Symptoms That Deserve Attention

Early signs of lung disease often go unnoticed. Individuals confuse mild breathlessness, cough, wheezing, fatigue, etc. with the normal process of aging. For timely management, it is crucial to recognise the early signs of lung disease. The warning signs involve:

Chronic Cough

• Chronic cough lasting more than a month
• Sometimes cough is accompanied by blood
• Persistent chronic cough might indicate chronic conditions like bronchitis, infection, emphysema, or tuberculosis

Wheezing

• Uneasy or noisy breathing is called wheezing
• Symptoms increase with narrowing or swelling of the throat
• Triggered by allergies, smoking, rigorous exercise

Dyspnea

• Shortness of breath (dyspnea) frequently
• Laboured or difficulty in breathing

Chronic Mucus

• Produced by the airways as a response to dust or dirt exposure
• Normal function of mucus/phlegm/sputum is keeping lungs healthy
• Prolonged mucus production is a chronic condition and must be taken seriously

Chronic Chest Pain

• Presence of chronic lung condition is often associated with lung disease
• Unexplained chest pain occurs while coughing or breathing 

*NOTE: The early signs of lung disease, when ignored, progress gradually. Certain other symptoms include fatigue, cyanosis, frequent respiratory infections, finger clubbing, pain or discomfort, fever, or sudden weight loss 

Lung Disease Causes: What Drives Progressive Respiratory Damage?

Lung Disease Causes include:

• Regular smoking (active or passive)
• Exposure to infections, including germs, fungi, molds, and bacteria
• Chronic inflammatory conditions like rheumatoid arthritis, scleroderma, lupus, sarcoidosis
• Exposure to harmful workplace hazards like asbestos, silica dust, coal, etc.
• Hypersensitivity or allergic reaction 

From Airway Obstruction to Fibrosis: Understanding the Two Major Patterns of Lung Damage

Chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis (PF) are chronic lung conditions that severely affect the lungs. The key differences in their mechanisms of development include:

COPD

• Obstructive condition that damages airways and alveoli (air sacs)
• The airways become swollen and narrow the passage
• Leads to excessive mucus production

Pulmonary Fibrosis

• Restrictive condition that leads to scarring or stiffening of the lung tissue
• Prolonged exposure to harmful substances and lung tissue damage provokes an immune response
• It leads to scarring of lung tissue; the lung hardens, making expansion and contraction difficult

Regenerative Medicine and Lung Repair: Exploring a Different Biological Approach

The management of chronic lung conditions involves the introduction of well-established conventional approaches. This includes medications (corticosteroids, anti-fibrotics), oxygen therapy, bronchodilators, smoking cessation, pulmonary rehabilitation, etc. None of the conventional therapeutics tend to reverse the damage at the cellular level. Currently, researchers are widely exploring regenerative medicine in the form of stem cell therapy to target lung disease at the cellular level. Mesenchymal stem cells (MSCs) are widely used for their regenerative abilities and send out paracrine signalling. The key focus areas include:

• Cellular regeneration of the damaged lung cells
• Support repair signlling, prevent damage of the surrounding cells
• Anti-inflammation and immunomodulation
• Influence inflammatory pathways, regulate oxidative stress, and tissue responses
• Facilitate alveolar epithelial cell regeneration, endothelial function, and restoration of lung tissue homeostasis

Stem Cell Therapy for COPD and Pulmonary Fibrosis: Where Does the Research Stand?

Researchers and clinicians are widely exploring stem cell therapy for COPD and stem cell therapy for Pulmonary Fibrosis in India and globally. Preclinical and early clinical applications have set potential trends. The key developments include:

Stem Cells Treatment for COPD

• COPD patients showed safety and tolerability of MSC introduction
• No adverse or worsening disease conditions are reported
• Reduced level of pro-inflammatory cytokines
• Decrease in infiltration of inflammatory cells (macrophages and neutrophils)
• Support regeneration of the damaged lung tissue
• MSCs released various growth factors that stimulated alveolar structure repair
• Improvement in forced expiratory volume and elevated level of C-reactive protein (CRP)
• Decreased level of exacerbation frequency [1]

Stem Cell Therapy for Pulmonary Fibrosis 

• Support lung function, improved tolerance to exercise
• Improvement in breathing, better rehabilitation
• Stabilization of the functional measures and improved quality of life for the patient
• Stem Cell Therapy for Pulmonary Fibrosis in India and globally has reported safety and tolerance of stem cells among the patients [2]

*NOTE: The clinical evidence consistency varied among the patients. The quality, source, isolation procedure, administration, characterization, storage condition, cell count, and viability all affect the outcome. One opting for advanced regenerative approaches must consult experienced clinicians and renowned clinics and set realistic expectations post-therapy. Clinicians currently combine stem cell treatment for COPD and PF with conventional approaches to improve therapeutic outcomes and the quality of life of the patient. Advancells, India, is a leading manufacturer and supplier of clinical-grade stem cells for various chronic conditions. The product isolation follows an internally standardized isolation protocol and is well-characterised. The products come with a Certificate of Authentication (CoA).   

The Road Ahead: Towards More Targeted and Biologically Informed Lung Therapies

• Recognition of the early signs of lung disease and lung disease causes is crucial in adapting treatment at an early stage
• Future research focuses on launching well-structured, large-scale clinical trials to establish long-term efficacy and safety
• Patients adopting advanced regenerative approaches must set realistic expectations, as the approach is at the trial stage and cannot be considered a standalone treatment

References

1. Lai S, Guo Z. Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option. Stem cell research & therapy. 2024 Sep 19;15(1):312. 
2. Cheng W, Zeng Y, Wang D. Stem cell-based therapy for pulmonary fibrosis. Stem Cell Research & Therapy. 2022 Oct 4;13(1):492. 

FAQ’s

Q- What are the early signs of lung damage?

Early lung damage signs include persistent cough, breathlessness, wheezing, chest tightness, fatigue, etc. Frequent respiratory infections or a noticeable decline in stamina may persist or gradually worsen.

Q- Can lung damage by COPD or pulmonary fibrosis be reversed?

It depends on the extent and nature of the damage. In COPD, structural changes (damage to the air sacs) are irreversible. Scarring in pulmonary fibrosis is irreversible. 

Q- How is stem cell therapy explored for COPD and pulmonary fibrosis?

Researchers use MSCs due to their ability to release signalling molecules that influence inflammation, immune responses, and cellular repair, which has attracted interest. While early research has shown encouraging possibilities, these approaches have not yet demonstrated consistent clinical benefits in COPD or pulmonary fibrosis.

Q- Is stem cell therapy for COPD available in India?

Yes, stem cell therapy for COPD is widely explored in India. Currently, clinicians are introducing stem cells as supportive therapeutics along with conventional treatment. They are not the standalone treatment option.